Pharmacology: Pharmacodynamics: Carbimazole is a thyroid reducing agent.
Pharmacokinetics: Carbimazole is rapidly metabolised to methimazole. The mean peak plasma concentration of methimazole is reported to occur one hour after a single dose of carbimazole. The apparent plasma half-life of methimazole is reported as 6.4 hours.